You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CVD

Showing 1 - 25 of 2,900
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cardiovascular Diseases Trial (HeartAge, HOPE-CVD Mobile App, Genetic Risk Score)

Not yet recruiting
  • Cardiovascular Diseases
  • HeartAge
  • +2 more
  • (no location specified)
Apr 23, 2023

Proteomics and Genomics Combined With CT to Predict CVD

Recruiting
  • Coronary Artery Disease Progression
    • Amsterdam, Netherlands
      Amsterdam UMC, location AMC
    Mar 23, 2023

    Cardiovascular Diseases (CVD) Trial (Heart Age, HOPE-CVD App, Communication of Genetic Risk Score)

    Not yet recruiting
    • Cardiovascular Diseases (CVD)
    • Heart Age
    • +2 more
    • (no location specified)
    Oct 24, 2023

    Medication Adherence Trial in Manhasset (5 Behavioral Change Techniques)

    Recruiting
    • Medication Adherence
    • 5 Behavioral Change Techniques
    • Manhasset, New York
      Northwell Health
    Jul 12, 2023

    AIVARIX in Detecting Signs C 1-2 Classes of CVD

    Not yet recruiting
    • Chronic Venous Disease
    • CVD
    • to estimate Sensitivity and Specificity AIVARIX app in detecting C1 and C2 classes of CVD
    • Moscow, Russian Federation
      Pirogov Russian National Research Medical University
    Nov 3, 2022

    Cardiovascular Risk Trial in Petaling Jaya (Plant Omega, Dietary therapy only)

    Not yet recruiting
    • Cardiovascular Risk
    • Plant Omega
    • Dietary therapy only
    • Petaling Jaya, Selangor, Malaysia
      Beacon Hospital Sdn Bhd
    May 21, 2023

    Cardiovascular Diseases, Physical Activity, Nutrition Trial (Mentoring Program, Enhanced Resources, Enhanced Engagement)

    Not yet recruiting
    • Cardiovascular Diseases
    • +2 more
    • Mentoring Program
    • +6 more
    • (no location specified)
    Aug 2, 2023

    Atherosclerosis, Cerebral Trial (didactic health education control, Transcendental Meditation technique)

    Completed
    • Atherosclerosis, Cerebral
    • didactic health education control
    • Transcendental Meditation technique
    • (no location specified)
    Nov 30, 2022

    Microtia, Dysbiosis, Alcohol Drinking Trial (Probiotic, Placebo)

    Not yet recruiting
    • Microtia
    • +4 more
    • Probiotic
    • Placebo
    • (no location specified)
    Dec 9, 2022

    Shigella Infection, Enterotoxigenic Escherichia Coli Infection Trial in Baltimore (strain CVD 1208S-122, Placebo)

    Not yet recruiting
    • Shigella Infection
    • Enterotoxigenic Escherichia Coli Infection
    • strain CVD 1208S-122
    • Placebo
    • Baltimore, Maryland
      University of Maryland, Baltimore, University of Maryland School
    Jul 26, 2022

    Cardiovascular Diseases, Type2diabetes Trial in Winnipeg (Peer mentorship and physical activity)

    Not yet recruiting
    • Cardiovascular Diseases
    • Type2diabetes
    • Peer mentorship and physical activity
    • Winnipeg, Manitoba, Canada
      University of Manitoba
    Feb 10, 2023

    Cholera Vaccination Trial in Baltimore (Vaxchora)

    Terminated
    • Cholera Vaccination
    • Baltimore, Maryland
      University of Maryland, Baltimore, Center for Vaccine Developmen
    Mar 4, 2022

    Acute Lymphoblastic Leukemia, Leukemia Trial in Houston (Ponatinib, Venetoclax, Mini-hyper CVD)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Leukemia
    • Houston, Texas
      MD Anderson Cancer Center
    Aug 23, 2022

    Cardiovascular Diseases, Type 2 Diabetes Trial in San Francisco (Educational Materials on the Cardiovascular Disease in Type 2

    Completed
    • Cardiovascular Diseases
    • Type 2 Diabetes
    • Educational Materials on the Cardiovascular Disease in Type 2 Diabetes (CVD-T2D)
    • Educational Materials on the CVD-T2D and Bundled Metabolic Panel
    • San Francisco, California
      QURE Healthcare
    Aug 17, 2022

    Obesity Trial (BI 456906, Placebo)

    Not yet recruiting
    • Obesity
    • BI 456906
    • Placebo
    • (no location specified)
    Oct 4, 2023

    Hypercholesterolemia, Cardiovascular Diseases Trial in Cincinnati (lerodalcibep, evolocumab, alirocumab)

    Active, not recruiting
    • Hypercholesterolemia
    • Cardiovascular Diseases
    • lerodalcibep
    • +2 more
    • Cincinnati, Ohio
    • +2 more
    Jul 13, 2022

    Pregnancy Related, Hypertension, Obesity Trial (COH, COH+)

    Not yet recruiting
    • Pregnancy Related
    • +3 more
    • COH
    • COH+
    • (no location specified)
    Aug 11, 2022

    Obesity, Cardiovascular Risk Factor Trial in Durham (Digital weight loss intervention)

    Enrolling by invitation
    • Obesity
    • Cardiovascular Risk Factor
    • Digital weight loss intervention
    • Durham, North Carolina
      Duke University Health System
    Jan 30, 2023

    SB and Cardiac Function and Structure in IHD

    Not yet recruiting
    • Cardiovascular Diseases
    • Sedentary Behavior
    • Activity pattern in CVD
    • (no location specified)
    Mar 14, 2023

    CVD Dysfunction in Hypertensive Disorders of Pregnancy

    Not yet recruiting
    • Cardiovascular Diseases
    • Pregnancy
      • Trieste, Italy
        IRCCS Burlo Garofolo
      Mar 28, 2023

      Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)

      Not yet recruiting
      • Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 23, 2022

      Heart Attack, Stroke, Cardiovascular Diseases Trial in Portland (CV WIZARD)

      Active, not recruiting
      • Heart Attack
      • +2 more
      • CV WIZARD
      • Portland, Oregon
        Kaiser Permanente Center for Health Research
      May 25, 2022

      The Geneva Covid-19 CVD Study

      Completed
      • COVID
      • CVD
      • Covid-19 + patients
      • Geneva, Switzerland
        Geneva University Hospital (HUG)
      Oct 18, 2021

      Cardiovascular Diseases, Hypertension, Diabetes Trial in New Orleans (Evidence-based interventions recommended by the 2019

      Not yet recruiting
      • Cardiovascular Diseases
      • +3 more
      • Evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD
      • New Orleans, Louisiana
        Tulane University
      Sep 26, 2023

      LV Function in Patients With CVD

      Recruiting
      • Stable Angina
      • Heart Failure
      • Group I
      • +2 more
      • Tanta, El-Gharbia, Egypt
        Tanta University Hospital
      Jun 21, 2023